Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methodsNGUYEN, Ha T; FRY, Alicia M; GUBAREVA, Larisa V et al.Antiviral therapy (London). 2012, Vol 17, Num 1, pp 159-173, issn 1359-6535, 15 p., bArticle

CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus ActivityYAMASHITA, Makoto; TOMOZAWA, Takanori; KAKUTA, Masayo et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 1, pp 186-192, issn 0066-4804, 7 p.Article

Neuraminidase Inhibitor Sensitivity and Receptor-Binding Specificity of Cambodian Clade 1 Highly Pathogenic H5N1 Influenza VirusNAUGHTIN, M; DYASON, J. C; MARDY, S et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 5, pp 2004-2010, issn 0066-4804, 7 p.Article

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007TASHIRO, Masato; MCKIMM-BRESCHKIN, Jennifer L; SAITO, Takehiko et al.Antiviral therapy (London). 2009, Vol 14, Num 6, pp 751-761, issn 1359-6535, 11 p.Article

In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza VirusesHURT, Aeron C; HOLIEN, Jessica K; BARR, Ian G et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4433-4440, issn 0066-4804, 8 p.Article

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillanceKASHIWAGI, Seizaburo; YOSHIDA, Sanae; YAMAGUCHI, Hiroki et al.International journal of antimicrobial agents (Print). 2012, Vol 40, Num 5, pp 381-388, issn 0924-8579, 8 p.Article

Usage des antiviraux en pédiatrieWEIL-OLIVIER, Catherine.MTP. Médecine thérapeutique pédiatrie. 2010, Vol 13, Num 4, pp 298-305, issn 1286-5494, 8 p.Article

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008SHEU, Tiffany G; DEYDE, Varough M; OKOMO-ADHIAMBO, Margaret et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 9, pp 3284-3292, issn 0066-4804, 9 p.Article

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single AdministrationKUBO, Shuku; TOMOZAWA, Takanori; KAKUTA, Masayo et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 3, pp 1256-1264, issn 0066-4804, 9 p.Article

CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory TractKOYAMA, Kumiko; TAKAHASHI, Makoto; OITATE, Masataka et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 11, pp 4845-4851, issn 0066-4804, 7 p.Article

Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removalBARRETT, Susan; MCKIMM-BRESCHKIN, Jennifer L.Antiviral research. 2014, Vol 108, pp 30-35, issn 0166-3542, 6 p.Article

Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy VolunteersISHIZUKA, Hitoshi; TOYAMA, Kaoru; YOSHIBA, Satoshi et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3873-3878, issn 0066-4804, 6 p.Article

Supratherapeutic oseltamivir levels during continuous dialysis: an expected riskESCHENAUER, Gregory A; LAM, Simon W.Intensive care medicine (Print). 2011, Vol 37, Num 2, issn 0342-4642, p. 371Article

Oseltamivir dose adjustment in an H1N1 patient requiring haemodialysisDOLLEY-HITZE, Thibault; VERDIER, Marie-Clémence; TRIBUT, Olivier et al.Intensive care medicine (Print). 2010, Vol 36, Num 9, pp 1618-1619, issn 0342-4642, 2 p.Article

Augmentation de la résistance à l'oseltamivir = More resistance to oseltamivir (Tamiflu)The Medical letter on drugs and therapeutics (Edition française). 2009, Vol 31, Num 4, pp 13-14, issn 0253-8512, 2 p.Article

Oséltamivir : saignements digestifs = Oseltamivir and digestive bleedingsLa Revue Prescrire. 2008, Vol 28, Num 293, pp 186-186, issn 0247-7750, 1 p.Article

Pharmacokinetics and Tolerability of Oseltamivir Combined with ProbenecidHOLODNIY, Mark; PENZAK, Scott R; DEYTON, Lawrence R et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 9, pp 3013-3021, issn 0066-4804, 9 p.Article

Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274YBURNHAM, Andrew J; BARANOVICH, Tatiana; MARATHE, Bindumadhav M et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2718-2730, issn 0066-4804, 13 p.Article

Oseltamivir: the real world dataFREEMANTLE, Nick; SHALLCROSS, L. J; KYTE, D et al.BMJ (Overseas and retired doctors ed.). 2014, Vol 348, Num 7953, pp 22-24, issn 1759-2151, 3 p.Article

Population Pharmacokinetics of Oseltamivir: Pediatrics through GeriatricsKAMAL, Mohamed A; VAN WART, Scott A; RAYNER, Craig R et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 3470-3477, issn 0066-4804, 8 p.Article

Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and TransmissionGHEDIN, Elodie; HOLMES, Edward C; DEPASSE, Jay V et al.The Journal of infectious diseases. 2012, Vol 206, Num 10, pp 1504-1511, issn 0022-1899, 8 p.Article

Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug OseltamivirSHI, Deshi; DONGFANG YANG; PRINSSEN, Eric P et al.The Journal of infectious diseases. 2011, Vol 203, Num 7, pp 937-942, issn 0022-1899, 6 p.Article

Nonclinical Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in the Central Nervous SystemHOFFMANN, Gerhard; FUNK, Christoph; FOWLER, Stephen et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 11, pp 4753-4761, issn 0066-4804, 9 p.Article

In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped virusesSU, Ching-Yao; WANG, Shi-Yun; SHIE, Jiun-Jie et al.Antiviral research. 2008, Vol 79, Num 3, pp 199-205, issn 0166-3542, 7 p.Article

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II StudyMARTY, Francisco M; MAN, Choy Y; ZHAO, Henry H et al.The Journal of infectious diseases. 2014, Vol 209, Num 4, pp 542-550, issn 0022-1899, 9 p.Article